[
  {
    "ts": null,
    "headline": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
    "summary": "FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.",
    "url": "https://finnhub.io/api/news?id=84121b8f240b66f24b63fbf5cd8063d75346daaad32de44b9a69e982b509e486",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784620,
      "headline": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
      "id": 133727377,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.",
      "url": "https://finnhub.io/api/news?id=84121b8f240b66f24b63fbf5cd8063d75346daaad32de44b9a69e982b509e486"
    }
  },
  {
    "ts": null,
    "headline": "SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System",
    "summary": "Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.",
    "url": "https://finnhub.io/api/news?id=f0a67a30afbbc9900df8473b3918add9e7b8edbb61c3da47d7334de4a402e986",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784560,
      "headline": "SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System",
      "id": 133727378,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Surmodics launches the Pounce XL Thrombectomy System, aiming to enhance clot removal efficiency, improve patient outcomes, and expand its portfolio of vascular interventions.",
      "url": "https://finnhub.io/api/news?id=f0a67a30afbbc9900df8473b3918add9e7b8edbb61c3da47d7334de4a402e986"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
    "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=6cb2059c4ca89c111c30965b209faa6ab6e918bc785727ffb627ac42ee39c27f",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743784440,
      "headline": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
      "id": 133744730,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Friday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=6cb2059c4ca89c111c30965b209faa6ab6e918bc785727ffb627ac42ee39c27f"
    }
  },
  {
    "ts": null,
    "headline": "RMD Stock Benefits From the Launch of NightOwl Across US",
    "summary": "Resmed launches NightOwl, an FDA-cleared home sleep apnea test, in the United States to diagnose OSA at home.",
    "url": "https://finnhub.io/api/news?id=9273381ee49fc4b303dcbf1291d04d31524e5d814807e867cd2fdc0e572fa3c2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743768360,
      "headline": "RMD Stock Benefits From the Launch of NightOwl Across US",
      "id": 133719490,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Resmed launches NightOwl, an FDA-cleared home sleep apnea test, in the United States to diagnose OSA at home.",
      "url": "https://finnhub.io/api/news?id=9273381ee49fc4b303dcbf1291d04d31524e5d814807e867cd2fdc0e572fa3c2"
    }
  },
  {
    "ts": null,
    "headline": "Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM",
    "summary": "TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.",
    "url": "https://finnhub.io/api/news?id=755482d90ed4dc218325d23601f310fa7865acd98f12f5d8e81a891378f96ee1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743763860,
      "headline": "Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM",
      "id": 133704733,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMO launches the Krios 5 Cryo-TEM, boosting productivity and performance with enhanced automation.",
      "url": "https://finnhub.io/api/news?id=755482d90ed4dc218325d23601f310fa7865acd98f12f5d8e81a891378f96ee1"
    }
  },
  {
    "ts": null,
    "headline": "Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks",
    "summary": "Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.",
    "url": "https://finnhub.io/api/news?id=54d243827568dcbb59d0c4c170382db90f4e781d8e3376954cb2bd594b9202c1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1743757287,
      "headline": "Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks",
      "id": 133704695,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season.",
      "url": "https://finnhub.io/api/news?id=54d243827568dcbb59d0c4c170382db90f4e781d8e3376954cb2bd594b9202c1"
    }
  }
]